IS6395A - Viðtaka mótlyf gegn kínínhröðun sem ekki eru peptíð - Google Patents

Viðtaka mótlyf gegn kínínhröðun sem ekki eru peptíð

Info

Publication number: IS6395A
Authority: IS; Iceland
Prior art keywords: quinine; antagonist; peptide; acceleration; receptor non
Prior art date: 1999-12-22

Application number

IS6395A

Other languages

English (en)

Icelandic (is)

Inventor

Christopher Horwell David

Andrew Lewthwaite Russel

Clive Pritchard Martin

Raphy Jennifer

Barth Hubert

Steiner Klaus

Schiefermayr Bernd

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-22

Filing date

2002-05-24

Publication date

2002-05-24

2000-02-22 Priority claimed from EP00103665A external-priority patent/EP1127875A1/fr

2002-05-24 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2002-05-24 Publication of IS6395A publication Critical patent/IS6395A/is

Links

LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 title 2
235000001258 Cinchona calisaya Nutrition 0.000 title 1
230000001133 acceleration Effects 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
229960000948 quinine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

IS6395A 1999-12-22 2002-05-24 Viðtaka mótlyf gegn kínínhröðun sem ekki eru peptíð IS6395A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17154099P	1999-12-22	1999-12-22
EP00103665A EP1127875A1 (fr)	2000-02-22	2000-02-22	Procédé de préparation de l'ester méthylique de l'alpha-diméthylaminométhyl-tryptophane
PCT/EP2000/013349 WO2001046176A2 (fr)	1999-12-22	2000-12-21	Antagonistes de recepteur de tachykinine non peptidique

Publications (1)

Publication Number	Publication Date
IS6395A true IS6395A (is)	2002-05-24

Family

ID=26070578

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6395A IS6395A (is)	1999-12-22	2002-05-24	Viðtaka mótlyf gegn kínínhröðun sem ekki eru peptíð

Country Status (18)

Country	Link
EP (1)	EP1244653A1 (fr)
JP (1)	JP2003518111A (fr)
KR (1)	KR20020062364A (fr)
CN (1)	CN1413206A (fr)
AP (1)	AP2002002556A0 (fr)
AU (1)	AU2370801A (fr)
BG (1)	BG106804A (fr)
BR (1)	BR0016626A (fr)
CA (1)	CA2399584A1 (fr)
IL (1)	IL150203A0 (fr)
IS (1)	IS6395A (fr)
MA (1)	MA26854A1 (fr)
MX (1)	MXPA02006282A (fr)
NO (1)	NO20022942L (fr)
OA (1)	OA12129A (fr)
PL (1)	PL357650A1 (fr)
SK (1)	SK8862002A3 (fr)
WO (1)	WO2001046176A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010516734A (ja)	2007-01-24	2010-05-20	グラクソグループリミテッド	３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジンまたはｒ（−）−２，４−ジアミノ−５−（２，３−ジクロロフェニル）−６−フルオロメチルピリミジンを含む医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0655055B1 (fr) *	1992-08-13	2000-11-29	Warner-Lambert Company	Antagonistes de tachykinine
AU2180600A (en) *	1998-12-18	2000-07-12	Warner-Lambert Company	Non-peptide nk1 receptors antagonists

2000
- 2000-12-21 AP APAP/P/2002/002556A patent/AP2002002556A0/en unknown
- 2000-12-21 AU AU23708/01A patent/AU2370801A/en not_active Abandoned
- 2000-12-21 SK SK886-2002A patent/SK8862002A3/sk unknown
- 2000-12-21 CN CN00817549A patent/CN1413206A/zh active Pending
- 2000-12-21 IL IL15020300A patent/IL150203A0/xx unknown
- 2000-12-21 KR KR1020027008007A patent/KR20020062364A/ko not_active Withdrawn
- 2000-12-21 WO PCT/EP2000/013349 patent/WO2001046176A2/fr not_active Ceased
- 2000-12-21 JP JP2001547086A patent/JP2003518111A/ja active Pending
- 2000-12-21 MX MXPA02006282A patent/MXPA02006282A/es unknown
- 2000-12-21 BR BR0016626-0A patent/BR0016626A/pt not_active Application Discontinuation
- 2000-12-21 PL PL00357650A patent/PL357650A1/xx not_active Application Discontinuation
- 2000-12-21 CA CA002399584A patent/CA2399584A1/fr not_active Abandoned
- 2000-12-21 EP EP00987477A patent/EP1244653A1/fr not_active Withdrawn
- 2000-12-21 OA OA1200200196A patent/OA12129A/en unknown
2002
- 2002-05-24 IS IS6395A patent/IS6395A/is unknown
- 2002-06-10 BG BG106804A patent/BG106804A/xx unknown
- 2002-06-14 MA MA26689A patent/MA26854A1/fr unknown
- 2002-06-19 NO NO20022942A patent/NO20022942L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK8862002A3 (en)	2002-11-06
OA12129A (en)	2006-05-05
MXPA02006282A (es)	2004-09-06
AU2370801A (en)	2001-07-03
CA2399584A1 (fr)	2001-06-28
BG106804A (en)	2003-03-31
KR20020062364A (ko)	2002-07-25
WO2001046176A3 (fr)	2002-07-04
NO20022942D0 (no)	2002-06-19
AP2002002556A0 (en)	2002-06-30
CN1413206A (zh)	2003-04-23
MA26854A1 (fr)	2004-12-20
NO20022942L (no)	2002-06-19
JP2003518111A (ja)	2003-06-03
IL150203A0 (en)	2002-12-01
EP1244653A1 (fr)	2002-10-02
PL357650A1 (en)	2004-07-26
BR0016626A (pt)	2002-11-05
WO2001046176A2 (fr)	2001-06-28

Publication	Publication Date	Title
MA25403A1 (fr)	2002-04-01	Ligandes de recepteur de melanocortine
NO20050429D0 (no)	2005-01-26	Substituert kinolin-CCR5-reseptorantagonister
DE60045492D1 (de)	2011-02-17	Navigationsvorrichtung
DE60044187D1 (de)	2010-05-27	Navigationsvorrichtung
DE60024949D1 (de)	2006-01-26	Objekterkennungsgerät
ATE400558T1 (de)	2008-07-15	Metabotropische glutamatrezeptor-antagonisten
DE60021371D1 (de)	2005-08-25	Piperidinderivate verwendbar als ccr5 antagonisten
ATE323817T1 (de)	2006-05-15	Aufhängevorrichtung
DE69940160D1 (de)	2009-02-05	Navigationsvorrichtung
DE60012340D1 (de)	2004-08-26	Airbagvorrichtung
DE60020001D1 (de)	2005-06-16	Navigationsvorrichtung
DE60031041D1 (de)	2006-11-16	Positionsdetektionsvorrichtung
ATE305920T1 (de)	2005-10-15	Bradykinin receptorantagoniste
DE69925837D1 (de)	2005-07-21	Mikromechanischer Sensor
NO20013997D0 (no)	2001-08-16	Reseptoranalyse
DE69930865D1 (de)	2006-05-24	Navigationsvorrichtung
DE50009018D1 (de)	2005-01-27	Positionssensor
DE60022272D1 (de)	2005-10-06	Airbag-Vorrichtung
DE60004471D1 (de)	2003-09-18	Fahrzeugaufhängungsvorrichtung
DE50015079D1 (de)	2008-05-15	Navigationsgerät
DE60042960D1 (de)	2009-10-29	Airbagvorrichtung
ATE370114T1 (de)	2007-09-15	Zwitterionische tachykinin-rezeptor-antagonisten
DE60122651D1 (de)	2006-10-12	Fahrzeugaufhängungsvorrichtung
DE50008526D1 (de)	2004-12-09	Positionsmesseinrichtung
MA25265A1 (fr)	2001-10-01	Antagoniste du recepteur de vitronectime.